PReS kindly thanks its Corporate Partners for their support of the Society's activities, educational programmes, and initiatives. We are pleased to acknowledge our partners below.
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease.
Our medicines reach nearly 300 million people worldwide.
Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases.
We are bringing brilliant ideas to life in rare disease areas with high unmet patient need.
We are experts on identifying breakthrough innovations, unlocking new therapies and leveling up global access to new treatments
Our global operational network and passionate team serve as the foundation for our success.
Vision
To transform everyday life for people living with rare diseases.
Mission
To identify, unlock and level up breakthrough therapies for people living with rare diseases.
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.
“Today, more than 1 million patients worldwide are treated with AbbVie’s immunology medicines, approved in more than 175 countries across 19 immune-mediated diseases that impact adult and pediatric populations.”
